IL18 and neoplasm: IL18, a pyroptosis-related inflammatory mediator, was observed to exert inflammation-dependent tumor-suppressive effects by promoting the differentiation, activity, and survival of tumor-infiltrating T cells in hepatocellular carcinoma (Markowitz et al., 2016).